ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
2.105
+0.005 (0.24%)
Apr 21, 2026, 9:42 AM EDT - Market open
ProKidney Market Cap
ProKidney has a market cap or net worth of $635.53 million as of April 21, 2026. Its market cap has increased by 158.45% in one year.
Market Cap
635.53M
Enterprise Value
368.04M
1-Year Change
158.45%
Ranking
Category
Stock Price
$2.11
Market Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $258.80M to $635.53M, an increase of 145.57%. That is a compound annual growth rate of 20.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 658.20M | -2.33% |
| Dec 31, 2025 | 673.90M | 36.72% |
| Dec 31, 2024 | 492.90M | 17.61% |
| Dec 29, 2023 | 419.10M | -73.75% |
| Dec 30, 2022 | 1.60B | 405.76% |
| Dec 31, 2021 | 315.70M | 21.99% |
| Jun 30, 2021 | 258.80M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prime Medicine | 688.84M |
| Kyverna Therapeutics | 680.97M |
| Adlai Nortye | 664.00M |
| Zevra Therapeutics | 632.91M |
| Eikon Therapeutics | 625.30M |
| Ocugen | 625.11M |
| Absci | 604.43M |
| Rigel Pharmaceuticals | 600.19M |